25 results for “systemic response”

Set a search alert

Research ArticleOpen accessIn the abstractPOST-HARVEST CONTROL OF APPLE BLUE MOLD UNDER COLD STORAGE CONDITIONSZiad B. Al-Rawashdeh, Muwaffaq R. KarajehTo control blue mold of apples caused by Penicillium expansum after harvest and during commercial cold storage, microwave exposure was investigated as a physical measure and compared with the use of calcium chloride and the systemic fungicide, carbendazime. Microwave exposure of Golden Delicious and Royal Gala apples at 2450 Mhz for 10, 30 and 45s was effective as 4% CaCl2 … …American Journal of Agricultural and Biological Sciences, Vol. 9, Issue 2 · 23 Jan 2014 · 7,521 accessesView PDF Cite

Research ArticleOpen accessIn the abstractJapanese Encephalitis Virus: An Emerging PathogenSneham Tiwari, Sai V.P. Chitti, Asha Mathur, Shailendra K. SaxenaJapanese Encephalitis Virus (JEV) is a flavivirus maintained in a zoonotic cycle which involves pigs, birds and Culex species of mosquitoes causing fatal encephalitis endemic most of Asia and as far as Australia from its putative origin in Indonesia and Malaysia. The principle vector is Culex mosquito, most important being Culex tritaenorhynchus, present in greatest density in rainy season (June … …Current Research in Virology, Vol. 1, Issue 1 · 2 Aug 2012 · 14,902 accessesView PDF Cite

Research ArticleOpen accessIn the abstractMicrobial Translocation and B Cell Dysfunction in Human Immunodeficiency Virus DiseaseWei JiangThe gut mucosal barrier disrupted in HIV disease, resulting in increased systemic exposure to microbial products such as Lipo Polys Accharide (LPS). The association of enhanced microbial translocation and B cell dysfunction in HIV disease is not fully understood. High dose and short term exposure of microbial Toll-Like Receptor (TLR) agonists were used as vaccine adjuvants, however, low dose and … …American Journal of Immunology, Vol. 8, Issue 2 · 30 Jun 2012 · 7,409 accessesView PDF Cite

Research ArticleOpen accessIn the abstractRole of IL-10 in Urinary Bladder Carcinoma and Bacillus Calmette-Guerin ImmunotherapyYi Luo, Eric J. Askeland, Mark R. Newton, Michael A. O’DonnellProblem statement: Bladder cancer is a common urologic cancer and intravesical Mycobacterium bovis Bacillus Calmette-Guerin (BCG) is the mainstay in the treatment of superficial bladder cancer. However, the current BCG therapy is not desirable with respect to its efficacy and side effects. Interleukin (IL)-10, a T helper type (Th) 2 cytokine, plays an important regulatory role in bladder cancer immunosurveillance … …American Journal of Immunology, Vol. 8, Issue 1 · 9 Mar 2012 · 8,005 accessesView PDF Cite

Research ArticleOpen accessIn the abstractCytokines as Adjuvants for Vaccine and Cellular Therapies for CancerChristian M. Capitini, Terry J. Fry, Crystal L. MackallProblem statement: The development of a potent vaccine that can help treat tumors resistant to conventional cytotoxic therapies remains elusive. While part of the problem may be that trials have focused on patients with bulky residual disease, the desire to maximize responses to the vaccine remains. Approach: The gamma (γ) family of cytokines offered a unique opportunity to support the … …American Journal of Immunology, Vol. 5, Issue 3 · 30 Sep 2009 · 14,348 accessesView PDF Cite